What is Cockerell Dermatopathology?
Cockerell Dermatopathology operates as a premier, family-oriented practice dedicated to the highest standards of diagnostic excellence. The firm provides a comprehensive suite of services, including consultative support and clinical trial management, catering to a diverse clientele that spans local, regional, and international dermatologic clinicians. Beyond its core diagnostic functions, the company distinguishes itself through a robust commitment to continuing education, hosting seminars that advance the specialty for both practitioners and patients. By prioritizing a seamless patient experience and maintaining rigorous billing support, the practice has established a reputation for reliability and clinical precision in a complex healthcare environment.
How much funding has Cockerell Dermatopathology raised?
Cockerell Dermatopathology has raised a total of $791K across 1 funding round:
Debt
$791K
Debt (2021): $791K with participation from PPP
Key Investors in Cockerell Dermatopathology
PPP
Public-Private Partnership
What's next for Cockerell Dermatopathology?
With the recent influx of capital, Cockerell Dermatopathology is poised to accelerate its strategic growth initiatives. The organization is expected to leverage this backing to broaden its clinical trial service offerings and invest in advanced diagnostic technologies that improve turnaround times and diagnostic accuracy. As the firm navigates the next phase of its lifecycle, the focus will likely remain on scaling its national footprint while maintaining the personalized, family-oriented service model that has defined its brand. This strategic expansion will be critical in maintaining its competitive edge as it continues to serve as a vital partner to dermatologists worldwide.
See full Cockerell Dermatopathology company page
